177 related articles for article (PubMed ID: 8494731)
21. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
Schmitt DA; Kisanuki K; Kimura S; Oka K; Pollard RB; Maeda H; Suzuki F
Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469
[TBL] [Abstract][Full Text] [Related]
22. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension].
Toge T; Jinushi K; Sawamura A; Matsuki K
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1677-80. PubMed ID: 1651687
[TBL] [Abstract][Full Text] [Related]
23. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
[TBL] [Abstract][Full Text] [Related]
24. [Stability of high molecular weight anticancer agent SMANCS and its transfer from oil-phase to water-phase. Comparative study with neocarzinostatin].
Hirayama S; Sato F; Oda T; Maeda H
Jpn J Antibiot; 1986 Mar; 39(3):815-22. PubMed ID: 3016359
[TBL] [Abstract][Full Text] [Related]
25. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
Oda T; Sato F; Maeda H
J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
[TBL] [Abstract][Full Text] [Related]
26. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
[TBL] [Abstract][Full Text] [Related]
27. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
[TBL] [Abstract][Full Text] [Related]
29. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
[TBL] [Abstract][Full Text] [Related]
30. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].
Maeda H; Konno T; Iwai K; Maki S; Tashiro S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681
[TBL] [Abstract][Full Text] [Related]
31. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI].
Shimizu T; Endou H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693
[TBL] [Abstract][Full Text] [Related]
32. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
Iwai K; Maeda H; Konno T
Cancer Res; 1984 May; 44(5):2115-21. PubMed ID: 6324996
[TBL] [Abstract][Full Text] [Related]
33. Combined effect of radiation and YM-881 (SMANCS) on murine tumors and bone marrow.
Ono K; Wandl E; Sasai K; Tsutsui K; Shibamoto Y; Takahashi M; Abe M
Acta Oncol; 1990; 29(4):455-9. PubMed ID: 2143908
[TBL] [Abstract][Full Text] [Related]
34. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
35. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
36. [Arterial infusion chemotherapy with SMANCS].
Nekohashi T; Maruno J; Sanjou A; Toda G
Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
[No Abstract] [Full Text] [Related]
37. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
38. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
39. [CT image of the liver cancer after administration of SMANCS/lipiodol].
Maki S; Konno T; Iwai K; Tashiro S; Otsuka N; Yamasaki K; Mizutani J; Miyauchi Y; Maeda H; Yokoyama I
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1603-10. PubMed ID: 3015036
[TBL] [Abstract][Full Text] [Related]
40. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
